Venrock Healthcare Capital Partners Iii, L.P.
10% Owner at Lycia Therapeutics, Inc. (LYCA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$37.7M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 27 NewSEC | LYCALycia Therapeutics, Inc. | Buy | 24,560new position | $25.68 | $631K | — |
| Oct 27 NewSEC | LYCALycia Therapeutics, Inc. | Buy | 28,37952,939 held (+116%) | $26.11 | $741K | — |
| Oct 27 NewSEC | LYCALycia Therapeutics, Inc. | Buy | 1,944,4446,777,176 held (+40%) | $18.00 | $35.0M | — |
| Oct 27 NewSEC | LYCALycia Therapeutics, Inc. | Buy | 8,2616,785,437 held (+0%) | $26.97 | $223K | — |
| Oct 27 NewSEC | LYCALycia Therapeutics, Inc. | Buy | 8,7296,794,166 held (+0%) | $25.84 | $226K | — |
| Oct 27 NewSEC | LYCALycia Therapeutics, Inc. | Buy | 31,0676,825,233 held (+0%) | $26.84 | $834K | — |
- Buy
10% Owner Venrock Healthcare Capital Partners Iii, L.P. bought $631K of LYCA at $25.68 — first open-market purchase in our records; opens a new position.
- Buy
10% Owner Venrock Healthcare Capital Partners Iii, L.P. bought $741K of LYCA at $26.11 — largest purchase by this insider in our records; raises the stake by 116%.
- Buy
10% Owner Venrock Healthcare Capital Partners Iii, L.P. bought $35.0M of LYCA at $18.00 — largest purchase by this insider in our records; raises the stake by 40%.